BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 38275602)

  • 1. Exploring Immune-Related Gene Profiling and Infiltration of Immune Cells in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma.
    Li J; Xi J
    Genes (Basel); 2024 Jan; 15(1):. PubMed ID: 38275602
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functional analysis of tumor-derived immunoglobulin lambda and its interacting proteins in cervical cancer.
    Wang J; Huang J; Ding H; Ma J; Zhong H; Wang F; Chen Y; Peng H
    BMC Cancer; 2023 Oct; 23(1):929. PubMed ID: 37784026
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Down-regulation of S1PR2 is correlated with poor prognosis and immune infiltrates in cervical squamous cell carcinoma and endocervical adenocarcinoma.
    Zhang Y; Wang H; Lu J; Lv Q; Yun B; Ge Z; Yan L
    Int J Immunopathol Pharmacol; 2023; 37():3946320231178131. PubMed ID: 37232164
    [No Abstract]   [Full Text] [Related]  

  • 4. Exploration of potential therapeutic and prognostic value of CXC chemokines in cervical squamous cell carcinoma and endocervical adenocarcinoma based on bioinformatics analysis.
    Wu C; Ma C; Yuan J; Zhou P
    Math Biosci Eng; 2021 Sep; 18(6):8201-8222. PubMed ID: 34814296
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A prognostic signature based on immune-related genes for cervical squamous cell carcinoma and endocervical adenocarcinoma.
    Liu J; Wu Z; Wang Y; Nie S; Sun R; Yang J; Cheng W
    Int Immunopharmacol; 2020 Nov; 88():106884. PubMed ID: 32795900
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification and Validation of the Anoikis-Related Gene Signature as a Novel Prognostic Model for Cervical Squamous Cell Carcinoma, Endocervical Adenocarcinoma, and Revelation Immune Infiltration.
    Jin QQ; Mei J; Hong L; Wang R; Wu SY; Wang SL; Jiang XY; Yang YT; Yao H; Zhang WY; Zhu YT; Ying J; Tian L; Chen G; Zhou SG
    Medicina (Kaunas); 2023 Feb; 59(2):. PubMed ID: 36837559
    [No Abstract]   [Full Text] [Related]  

  • 7. MLK4 as an immune marker and its correlation with immune infiltration in Cervical squamous cell carcinoma and endocervical adenocarcinoma(CESC).
    Gong M; Shen F; Li Y; Ming L; Hong L
    PLoS One; 2023; 18(8):e0290462. PubMed ID: 37594950
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pain-Related Gene Solute Carrier Family 24 Member 3 Is a Prognostic Biomarker and Correlated with Immune Infiltrates in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma: A Study via Integrated Bioinformatics Analyses and Experimental Verification.
    Zhou S; Jin Q; Yao H; Ying J; Tian L; Jiang X; Yang Y; Jiang X; Gao W; Zhang W; Zhu Y; Cao W
    Comput Math Methods Med; 2023; 2023():4164232. PubMed ID: 36798148
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Decreased expression of CLCA2 and the correlating with immune infiltrates in patients with cervical squamous cell carcinoma: A bioinformatics analysis.
    Yang X; Cao JL; Yang FN; Li XF; Tao LM; Wang F
    Taiwan J Obstet Gynecol; 2021 May; 60(3):480-486. PubMed ID: 33966732
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The immune landscape and prognostic analysis of CXCL8 immune-related genes in cervical squamous cell carcinoma.
    Zhang X; Yang J; Feng Q; Gu L; Qin G; Cheng C; Hou S; Shi Z
    Environ Toxicol; 2024 Apr; ():. PubMed ID: 38597597
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of a necroptosis-related prognostic gene signature associated with tumor immune microenvironment in cervical carcinoma and experimental verification.
    Sun K; Huang C; Li JZ; Luo ZX
    World J Surg Oncol; 2022 Oct; 20(1):342. PubMed ID: 36253777
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel prognostic signature based on cancer stemness and metabolism-related genes for cervical squamous cell carcinoma and endocervical adenocarcinoma.
    Wang Y; Han Y; Jin L; Ji L; Liu Y; Lin M; Zhou S; Yang R
    Aging (Albany NY); 2024 Apr; 16(8):7293-7310. PubMed ID: 38656879
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel Prognostic Biomarkers for Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma (CESC) Patients via Analysis of Competing Endogenous RNA (ceRNA) Network.
    Dong Y; Wen W; Yuan T; Liu L; Li X
    Dis Markers; 2023; 2023():1766080. PubMed ID: 36817087
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic Value and Immune Infiltration of HPV-Related Genes in the Immune Microenvironment of Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma.
    Gan Q; Mao L; Shi R; Chang L; Wang G; Cheng J; Chen R
    Cancers (Basel); 2023 Feb; 15(5):. PubMed ID: 36900213
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Necroptosis-related lncRNA signature predicts prognosis and immune response for cervical squamous cell carcinoma and endocervical adenocarcinomas.
    Lin Z; Zou J; Sui X; Yao S; Lin L; Wang J; Zhao J
    Sci Rep; 2022 Sep; 12(1):16285. PubMed ID: 36175606
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of ferroptosis-related molecular subtypes and a methylation-related ferroptosis gene prognostic signature in cervical squamous cell carcinoma.
    Yu L; Gao Z; Li Z; Liu P; Gao Y; Liang G
    J Cancer Res Clin Oncol; 2023 Nov; 149(16):14673-14689. PubMed ID: 37584713
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The New Biomarker for Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma (CESC) Based on Public Database Mining.
    Ding H; Xiong XX; Fan GL; Yi YX; Chen YR; Wang JT; Zhang W
    Biomed Res Int; 2020; 2020():5478574. PubMed ID: 32351997
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A multi-omics-based investigation of the prognostic and immunological impact of necroptosis-related mRNA in patients with cervical squamous carcinoma and adenocarcinoma.
    Zou J; Lin Z; Jiao W; Chen J; Lin L; Zhang F; Zhang X; Zhao J
    Sci Rep; 2022 Oct; 12(1):16773. PubMed ID: 36202899
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Upregulation of CCT3 promotes cervical cancer progression through FN1.
    Dou L; Zhang X
    Mol Med Rep; 2021 Dec; 24(6):. PubMed ID: 34651664
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fatty acid synthase (FASN) inhibits the cervical squamous cell carcinoma (CESC) progression through the Akt/mTOR signaling pathway.
    Lin Q; Jiang Y; Zhou F; Zhang Y
    Gene; 2023 Jan; 851():147023. PubMed ID: 36375657
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.